Research scientist Maria Laura Gennaro deploys her immunology and microbiology expertise, honed through decades of studying tuberculosis, in the world’s fight against COVID-19.
COVID-19 has reached many sub-Saharan African countries that are already suffering from malnutrition and disease, under-resourced health systems, and limited economic funding. Richard Marlink, director of Rutgers Global Health Institute and a leader in the global response to HIV/AIDS, discusses how this pandemic is likely to impact the African region and what can be done to help these countries.
Core faculty member David Alland and fellow Rutgers researcher Soumitesh Chakravorty received the Edison Patent Award for developing a rapid automated tuberculosis test that shortens the time it takes to get a diagnosis from seven weeks to two hours.
The Lattimore Food Pantry ensures that tuberculosis patients—taking a cocktail of medications—are well fed for the six months necessary for treatment.
Tuberculosis is a global threat, with the heaviest burden falling on people living in urban slums. Stephan Schwander is investigating the role urban outdoor air pollution might play.
A mathematician may not be an obvious choice when forming partnerships in health-related investigations, but the idea of applying math in ways that impact people’s lives is something that Benedetto Piccoli, an applied mathematics scholar, finds exciting.
Tuberculosis researcher Christopher Vinnard of Rutgers’ Public Health Research Institute is developing a urine test that can pinpoint—easily and resourcefully—the effectiveness of patients’ TB treatment dosages. This new test would be more accessible to clinicians in low-income countries.
An international team that includes Rutgers scientists has made significant progress in developing a urine diagnostic test that can quickly, easily and inexpensively identify tuberculosis infection in people also infected with HIV. The findings were announced at the September 26, 2018, United Nations meeting on TB.